Lote Hazel, Mannion Ethna, Cook Terence, Cairns Thomas, Savage Philip
Medical Oncology, Imperial Hospitals NHS Trust, Charing Cross Hospital, London W6 8RF, UK.
J Med Case Rep. 2013 Mar 1;7:59. doi: 10.1186/1752-1947-7-59.
Adenocarcinoma of the seminal vesicles is a very rare malignancy, with less than 100 cases reported worldwide. It is documented to have a poor prognosis, with the majority of patients developing metastatic disease, most commonly in the prostate, bladder and rectum. Currently there is no standard treatment for metastatic disease and the limited reports of treatment with radiotherapy, chemotherapy and hormonal (anti-androgenic) therapy show that they are generally of modest benefit. The association between malignancy and an increased risk of autoimmune vasculitis has been demonstrated in a number of malignancies, but to date there have been no documented cases of adenocarcinoma of the seminal vesicles associated with anti-neutrophil cytoplasmic antibody vasculitis.
In this report we describe the case of a 55-year-old Caucasian man with metastatic adenocarcinoma of the seminal vesicles. He previously had received chemotherapy treatment for advanced testicular cancer and later presented with hemospermia. He subsequently developed c-antineutrophil cytoplasmic antibody vasculitis requiring intensive immunosuppression and renal dialysis.
Adenocarcinoma of the seminal vesicles is a rare diagnosis and our case is more unusual in that our patient previously had chemotherapy treatment for advanced testicular cancer and went on to develop severe antineutrophil cytoplasmic antibody vasculitis when diagnosed with metastatic seminal vesicle cancer. This case illustrates that autoimmune vasculitis can occur in any patient with malignancy and an early referral to the renal team combined with renal biopsy can assist in the earlier diagnosis and more successful management of these rare events. This case should be of interest to oncologists, renal physicians, urologists and general physicians who encounter patients presenting with hemospermia or vasculitis.
精囊腺癌是一种极为罕见的恶性肿瘤,全球报告的病例不足100例。据记载,其预后较差,大多数患者会发生转移性疾病,最常见于前列腺、膀胱和直肠。目前,对于转移性疾病尚无标准治疗方法,而关于放疗、化疗和激素(抗雄激素)治疗的有限报告表明,这些治疗通常益处不大。在多种恶性肿瘤中已证实恶性肿瘤与自身免疫性血管炎风险增加之间存在关联,但迄今为止,尚无精囊腺癌与抗中性粒细胞胞浆抗体血管炎相关的病例记录。
在本报告中,我们描述了一名55岁白种男性精囊转移性腺癌的病例。他之前曾接受晚期睾丸癌的化疗,后来出现血精。随后他发展为抗中性粒细胞胞浆抗体血管炎,需要强化免疫抑制和肾脏透析。
精囊腺癌是一种罕见的诊断,我们的病例更为特殊,因为我们的患者之前曾接受晚期睾丸癌的化疗,在被诊断为精囊转移性癌时继而发展为严重的抗中性粒细胞胞浆抗体血管炎。该病例表明,自身免疫性血管炎可发生于任何恶性肿瘤患者,早期转诊至肾脏科团队并结合肾脏活检有助于这些罕见事件的早期诊断和更成功的管理。该病例应引起肿瘤学家、肾脏内科医生、泌尿科医生和普通内科医生的兴趣,他们会遇到出现血精或血管炎的患者。